Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer

por Evanno, Emilie, Godet, Julie, Piccirilli, Nathalie, Guilhot, Joëlle, Milin, Serge, Gombert, Jean Marc, Fouchaq, Benoit, Roche, Joëlle
Publicado 2017

Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells

por Roche, Joëlle, Nasarre, Patrick, Gemmill, Robert, Baldys, Aleksander, Pontis, Julien, Korch, Christopher, Guilhot, Joëlle, Ait-Si-Ali, Slimane, Drabkin, Harry
Publicado 2013

Erratum: Roche, J. et al. Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells. Cancers, 2013, 5, 334–356

por Roche, Joëlle, Nasarre, Patrick, Gemmill, Robert, Baldys, Aleksander, Pontis, Julien, Korch, Christopher, Guilhot, Joëlle, Ait-Si-Ali, Slimane, Drabkin, Harry
Publicado 2016

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia

por Bruzzoni-Giovanelli, Heriberto, González, Juan R., Sigaux, François, Villoutreix, Bruno O., Cayuela, Jean Michel, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Poyet, Jean-Luc, Rousselot, Philippe
Publicado 2015

High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients

por Delord, Marc, Rousselot, Philippe, Cayuela, Jean Michel, Sigaux, François, Guilhot, Joëlle, Preudhomme, Claude, Guilhot, François, Loiseau, Pascale, Raffoux, Emmanuel, Geromin, Daniela, Génin, Emmanuelle, Calvo, Fabien, Bruzzoni-Giovanelli, Heriberto
Publicado 2013

Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents

por Millot, Frédéric, Guilhot, Joëlle, Suttorp, Meinolf, Güneş, Adalet Meral, Sedlacek, Petr, De Bont, Eveline, Li, Chi Kong, Kalwak, Krzysztof, Lausen, Birgitte, Culic, Srdjana, Dworzak, Michael, Kaiserova, Emilia, De Moerloose, Barbara, Roula, Farah, Biondi, Andrea, Baruchel, André
Publicado 2017

Oral CHOP‐like chemotherapy in 60–80 years‐old patients with diffuse large B‐cell lymphoma

por Guidez, Stephanie, Lacotte‐Thierry, Laurence, Tomowiak, Cecile, Princet, Isabelle, Dreyfus, Brigitte, Olivier, Gaelle, Fleck, Emmanuel, Corby, Anne, Motard, Carine, Barrier, Jocelyn, Machet, Antoine, Le Dû, Katell, Debiais‐Delpech, Celine, Chabin, Michele, Leleu, Xavier, Guilhot, Joëlle, Delwail, Vincent
Publicado 2019

Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

por Payen, Didier M., Guilhot, Joelle, Launey, Yoann, Lukaszewicz, Anne Claire, Kaaki, Mahmoud, Veber, Benoit, Pottecher, Julien, Joannes-Boyau, Olivier, Martin-Lefevre, Laurent, Jabaudon, Matthieu, Mimoz, Olivier, Coudroy, Rémi, Ferrandière, Martine, Kipnis, Eric, Vela, Carlos, Chevallier, Stéphanie, Mallat, Jihad, Robert, René
Publicado 2015

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

por Rousselot, Philippe, Prost, Stéphane, Guilhot, Joelle, Roy, Lydia, Etienne, Gabriel, Legros, Laurence, Charbonnier, Aude, Coiteux, Valérie, Cony‐Makhoul, Pascale, Huguet, Francoise, Cayssials, Emilie, Cayuela, Jean‐Michel, Relouzat, Francis, Delord, Marc, Bruzzoni‐Giovanelli, Heriberto, Morisset, Laure, Mahon, François‐Xavier, Guilhot, François, Leboulch, Philippe
Publicado 2016

Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study

por Rea, Delphine, Henry, Guylaine, Khaznadar, Zena, Etienne, Gabriel, Guilhot, François, Nicolini, Franck, Guilhot, Joelle, Rousselot, Philippe, Huguet, Françoise, Legros, Laurence, Gardembas, Martine, Dubruille, Viviane, Guerci-Bresler, Agnès, Charbonnier, Aude, Maloisel, Frédéric, Ianotto, Jean-Christophe, Villemagne, Bruno, Mahon, François-Xavier, Moins-Teisserenc, Hélène, Dulphy, Nicolas, Toubert, Antoine
Publicado 2017

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL

por Pfirrmann, Markus, Mahon, Francois-Xavier, Dulucq, Stéphanie, Hochhaus, Andreas, Panayiotidis, Panayiotis, Almeida, Antonio, Mayer, Jiri, Hjorth-Hansen, Henrik, Janssen, Jeroen J. W. M., Mustjoki, Satu, Martinez-Lopez, Joaquín, Vestergaard, Hanne, Ehrencrona, Hans, Kairisto, Veli, Machová Poláková, Kateřina, Emmanuel Nicolini, Franck, Hofmann, Wolf-Karsten, Guilhot, Joëlle, Saussele, Susanne, Richter, Johan
Publicado 2023

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

por Padula, William V., Larson, Richard A., Dusetzina, Stacie B., Apperley, Jane F., Hehlmann, Rudiger, Baccarani, Michele, Eigendorff, Ekkehard, Guilhot, Joelle, Guilhot, Francois, Hehlmann, Rudiger, Mahon, Francois-Xavier, Martinelli, Giovanni, Mayer, Jiri, Müller, Martin C., Niederwieser, Dietger, Saussele, Susanne, Schiffer, Charles A., Silver, Richard T., Simonsson, Bengt, Conti, Rena M.
Publicado 2016

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

por Pfirrmann, Markus, Clark, Richard E., Prejzner, Witold, Lauseker, Michael, Baccarani, Michele, Saussele, Susanne, Guilhot, François, Heibl, Sonja, Hehlmann, Rüdiger, Faber, Edgar, Turkina, Anna, Ossenkoppele, Gert, Höglund, Martin, Zaritskey, Andrey, Griskevicius, Laimonas, Olsson-Strömberg, Ulla, Everaus, Hele, Koskenvesa, Perttu, Labar, Boris, Sacha, Tomasz, Zackova, Daniela, Cervantes, Francisco, Colita, Adriana, Zupan, Irena, Bogdanovic, Andrija, Castagnetti, Fausto, Guilhot, Joëlle, Hasford, Joerg, Hochhaus, Andreas, Hoffmann, Verena S.
Publicado 2020